ProtaGene Email Format
Biotechnology ResearchBaden-Württemberg, Germany51-200 Employees
ProtaGene is a contract research organization that focuses on advanced analytics for biologics and gene and cell therapies. It provides integrated protein- and gene-analysis capabilities across the full development to commercialization cycle, helping biopharmaceutical programs characterize and validate biologic therapeutics and gene/cell therapy platforms. The business evolved from the merger of Protagen Protein Services in Europe and BioAnalytix in the US, with GeneWerk’s capabilities added in 2021 to broaden its analytical platform across continents. Headquartered in Heilbronn, in the Baden-Württemberg region of Germany, ProtaGene operates across four sites in Europe and North America and serves biopharmaceutical and gene-therapy developers worldwide. In May 2026, it announced a strategic partnership with Merck Life Science (MilliporeSigma in the US and Canada) to offer comprehensive testing across the entire product lifecycle, from early development through GMP release testing.